Next Article in Journal
Current Challenges and Future Directions in the Multimodal Management of Gastric Cancer with Peritoneal Metastases
Previous Article in Journal
Systematic Exploration of Molecular Mechanisms and Natural Herbal Therapeutic Strategies for Cancer Cachexia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199

by
Luigi Giovanni Cecchi
1,2,†,
Marta Aliprandi
1,2,*,†,
Fabio De Vincenzo
2,
Matteo Perrino
2,
Nadia Cordua
2,
Federica Borea
3,
Alessandro Bertocchi
1,2,
Antonio Federico
1,2,
Giuseppe Marulli
1,4,
Armando Santoro
1,2,
Giovanni Luca Ceresoli
5,*,‡ and
Paolo Andrea Zucali
1,2,‡
1
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy
2
Department of Oncology IRCCS, Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
3
Department of Oncology, Cernusco sul Naviglio, ASST Melegnano e Martesana, 20063 Milan, Italy
4
Division of Thoracic Surgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy
5
Department of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work as co-first authors.
These authors contributed equally to this work as co-last authors.
Cancers 2026, 18(1), 103; https://doi.org/10.3390/cancers18010103
Submission received: 5 December 2025 / Accepted: 17 December 2025 / Published: 29 December 2025

Text Correction

There was an error in the original publication [1]. The following sentence is missing in the Section 6 Dicussion, Paragraph 4: It is notable that, among the surgical community, there is a general agreement that P/D should be privileged over EPP when technically feasible, as results are comparable in term of DFS and OS but with significantly lower morbidity and mortality, thus leaving more chance for adjuvant treatments and improving quality of life [102].
A correction has been made to Section 6 Discussion, Paragraph 4.
Considering the results of the EORTC 1205 study, the decision on each individual case should be based on the careful evaluation of various factors, including the disease extension, the type of surgical intervention, and the risk factors for postoperative morbidity. It is notable that, among the surgical community, there is a general agreement that P/D should be privileged over EPP when technically feasible, as results are comparable in term of DFS and OS but with significantly lower morbidity and mortality, thus leaving more chance for adjuvant treatments and improving quality of life [102].

Reference Correction

In the original publication, there was an error in the Reference list. The reference “Marulli, G.; Breda, C.; Ratto, G.B.; Leoncini, G.; Alloisio, M.; Infante, M.; Luzzi, L.; Paladini, P.; Oliaro, A.; Ruffini, E.; et al. Pleurectomy-decortication in malignant pleural mesothelioma: Are different surgical techniques associated with different outcomes? Results from a multicentre study. Eur. J. Cardiothorac. Surg. 2017, 52, 63–69. https://doi.org/10.1093/ejcts/ezx079” was not included in the reference list. The correct reference number is [102].
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Cecchi, L.G.; Aliprandi, M.; De Vincenzo, F.; Perrino, M.; Cordua, N.; Borea, F.; Bertocchi, A.; Federico, A.; Marulli, G.; Santoro, A.; et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cecchi, L.G.; Aliprandi, M.; De Vincenzo, F.; Perrino, M.; Cordua, N.; Borea, F.; Bertocchi, A.; Federico, A.; Marulli, G.; Santoro, A.; et al. Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199. Cancers 2026, 18, 103. https://doi.org/10.3390/cancers18010103

AMA Style

Cecchi LG, Aliprandi M, De Vincenzo F, Perrino M, Cordua N, Borea F, Bertocchi A, Federico A, Marulli G, Santoro A, et al. Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199. Cancers. 2026; 18(1):103. https://doi.org/10.3390/cancers18010103

Chicago/Turabian Style

Cecchi, Luigi Giovanni, Marta Aliprandi, Fabio De Vincenzo, Matteo Perrino, Nadia Cordua, Federica Borea, Alessandro Bertocchi, Antonio Federico, Giuseppe Marulli, Armando Santoro, and et al. 2026. "Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199" Cancers 18, no. 1: 103. https://doi.org/10.3390/cancers18010103

APA Style

Cecchi, L. G., Aliprandi, M., De Vincenzo, F., Perrino, M., Cordua, N., Borea, F., Bertocchi, A., Federico, A., Marulli, G., Santoro, A., Ceresoli, G. L., & Zucali, P. A. (2026). Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199. Cancers, 18(1), 103. https://doi.org/10.3390/cancers18010103

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop